CD2 and head and neck squamous cell carcinoma: This outcome is equivalent to a study’s findings, which showed that one probiotic, Lactobacillus brevis CD2, had decreased the incidence of radio chemotherapy-induced OM (grades 3 and 4) in patients with head and neck squamous cell carcinoma who were receiving chemoradiation therapy [25,28].